ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP25

From Denial of Spondyloarthritis to Becoming a Support Group Leader and Medical Doctor of Rheumatology: A Patient’s Perspective

Shung Chiu1 and Mei Nee Chiu2, 1Spondylitis Association of America, Ludhiana, Punjab, India, 2University Institute of Pharmaceutical Sciences, Panjab University, Ludhiana, Punjab, India

Meeting: ACR Convergence 2022

Keywords: Ankylosing spondylitis (AS), Back pain, Disease-Modifying Antirheumatic Drugs (Dmards), Nonsteroidal antiinflammatory drugs (NSAIDs), spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Patient Perspectives

Session Type: Patient Perspectives

Session Time: 5:00PM-6:00PM

Background/Purpose: From being a table tennis champion to getting into medical school, I thought my life was smooth sailing. But little did I know it was all going to change.

In February of 2018, the day before I turned 22, I started experiencing back pain, fever, and diarrhea. The fever and diarrhea resolved in 3 days but the pain remained and progressed over the next 2 months leaving me bedridden. My doctor suspected it to be Spondyloarthritis (SpA) after the HLA-B27 blood test came back positive and the MRI of my spine showed changes. I was prescribed Etoricoxib, a non-steroidal anti-inflammatory drugs (NSAIDs) followed by Sulfasalazine, a disease-modifying anti-rheumatic drug (DMARD) for treatment, however they only provided partial relief. Unconvinced and in search of an alternate diagnosis, I underwent a series of inconclusive medical visits with different doctors and investigations, only to arrive at a dead end. Several diagnoses and medications left me more confused and distraught. All this happened during the last year of medical school when my colleagues were preparing to embark upon their careers while I was in fear of my future uncertainties, questioning whether I will ever get better.

Intervention: Desperate for a cure, I tried everything:- Alternative medicine, physiotherapy, and low impact exercises such as swimming, cycling and the use of orthotics but nothing worked. Losing all hope I had spiralled to my lowest point.

I decided to take a break from my studies and, with the help of my family, I went to stay with my relatives abroad.The trip made me realize that the world had so much to offer, and I shouldn’t waste it self-pitying.

With a new perspective, I was determined to get better. Luckily, I eventually found a doctor who understood my predicament and helped me accept my diagnosis of SpA. From that day onwards, I never looked back. I understood my limitations and set my expectations accordingly. With the same medications and exercise routine, I showed more improvement. Slowly and steadily, I got back into my medical training and became a doctor.

In retrospect I now realise that accpeting my diagnosis was the hard part.

Maintenance: I live by the mantra, “Not to over-exert the body on your good days and always strive to be active on your bad days”. Movement, be it playing sports, cooking food, travelling, or anything that inspires you to move is the key to recovery in SpA.

I currently swim on regular basis and have started playing table tennis again.With each passing day, I am getting better while learning to incorporate new treatments to my routine like yoga, wim-hof breathing, meditation, and tai-chi. There has been a significant improvement in my strength, pain threshold, flexibility and overall fitness.

Quality of Life: Now motivated by my condition every day, I am a member of the Spondylitis Association of America and their 1st International Support Group Leader, hoping to inspire people like me to live their best life. I am also working as a medical officer in rheumatology under the leadership of same doctor who guided me through my SpA journey.

My message for readers is a line taken from my favourite movie, Kung Fu Panda:

“Your story may not have such a happy beginning but that doesn’t make you who you are,
It is the rest of your story about who you choose to be”.

Supporting image 1

Timeline of my journey with SpA

Supporting image 2

Things that kept me going
My Profession, My Routine ,My Mentor and My Rheumatology Dream Team
#StandingTallwithAS

Supporting image 3

Support Group Leader (India) with Spondylitis Association of America


Disclosures: S. Chiu, None; M. Chiu, None.

To cite this abstract in AMA style:

Chiu S, Chiu M. From Denial of Spondyloarthritis to Becoming a Support Group Leader and Medical Doctor of Rheumatology: A Patient’s Perspective [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/from-denial-of-spondyloarthritis-to-becoming-a-support-group-leader-and-medical-doctor-of-rheumatology-a-patients-perspective/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/from-denial-of-spondyloarthritis-to-becoming-a-support-group-leader-and-medical-doctor-of-rheumatology-a-patients-perspective/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology